Antimycobacterial screening of traditional medicinal plants using the microplate resazurin assay

Canadian Journal of Microbiology

Volumn 56, Issue 6, 2010, Pages 487-494

  Webster, Duncan ^a   Lee, Timothy D G ^b   Moore, Jill ^b   Manning, Tracy ^c   Kunimoto, Dennis ^c   LeBlanc, Darren ^d   Johnson, John A ^d   Gray, Christopher A ^d  

^a SAINT JOHN REGIONAL HOSPITAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^d UNIVERSITY OF NEW BRUNSWICK   (Canada)

Author keywords

Acorus calamus; Heracleum maximum; Mycobacteria; Tuberculosis

Indexed keywords

ACORUS CALAMUS; ANTI-MYCOBACTERIAL; ANTIMYCOBACTERIAL ACTIVITY; AQUEOUS EXTRACTS; GLOBAL HEALTH; HERACLEUM MAXIMUM; HUMAN CELL LINES; IN-VITRO; JUNIPERUS COMMUNIS; M. TUBERCULOSIS; MEDICINAL PLANTS; MICROPLATES; MTT ASSAYS; MYCOBACTERIA; MYCOBACTERIUM TUBERCULOSIS STRAINS; NORTH AMERICAN; PULMONARY INFECTIONS; RESAZURIN; SYMPLOCARPUS; TUBERCULOSIS;

BACTERIOLOGY; CELL CULTURE; PLANTS (BOTANY);

SOLVENT EXTRACTION;

HERBACEOUS AGENT; RESAZURIN; RIFAMPICIN; OXAZINE DERIVATIVE; PLANT EXTRACT; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TUBERCULOSTATIC AGENT; XANTHENE DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ASSAY; CELL ORGANELLE; DICOTYLEDON; INFECTIOUS DISEASE; MEDICINAL PLANT; TOXICITY; WEED;

ACORUS CALAMUS; ANTIBACTERIAL ACTIVITY; ARALIA; ARTICLE; BACILLUS; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; HERACLEUM; HUMAN; HUMAN CELL; JUNIPERUS; MEDICINAL PLANT; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM BOVIS;

ACORUS CALAMUS; ARALIA NUDICAULIS; CORYNEBACTERINEAE; HERACLEUM MAXIMUM; JUNIPERUS COMMUNIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; SYMPLOCARPUS FOETIDUS;

ANTITUBERCULAR AGENTS; DRUG EVALUATION, PRECLINICAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; OXAZINES; PLANT EXTRACTS; PLANTS, MEDICINAL; TETRAZOLIUM SALTS; THIAZOLES; XANTHENES;

EID: 78049434548     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/W10-035     Document Type: Article

References (27)

1. Bergeron, C., Marston, A., Gauthier, R., and Hostettmann, K. 1996. Screening of plants used by North American Indians for antifungal, bactericidal, larvicidal, and molluscicidal activities. Int. J. Pharmacog. 34(4): 233-242.doi:10.1076/phbi.34.4.233.13224.
2. Bock, B.K. 1966. The Micmac Indians of Restigouche: history and contemporary description. National Museum of Canada, Bulletin 213, Anthropological Series 77, Ottawa, Ont.
3. Centers for Disease Control and Prevention. 2006a. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb. Mortal. Wkly. Rep. 55(11): 301-305.PMID:16557213.
4. Centers for Disease Control and Prevention. 2006b. Revised definition of extensively drug-resistant tuberculosis. MMWR Morb. Mortal. Wkly. Rep. 55: 1176.
5. Chandler, R.F., Freeman, L., and Hooper, S.N. 1979. Herbal remedies of the maritime Indians. J. Ethnopharmacol. 1(1): 49-68.doi:10.1016/0378-8741(79)90016-3. PMID:544949.
6. Collins, L.A., and Franzblau, S.G. 1997. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41(5): 1004-1009.PMID:9145860.
7. Corbett, E.L., Watt, C.J., Walker, N., Maher, D., Williams, B.G., Raviglione, M.C., and Dye, C. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163(9): 1009-1021.doi:10.1001/archinte.163.9.1009. PMID:12742798.
8. Gupta, R., and Espinal, M.; Stop TB Working Group on DOTS-Plus for MDR-TB. 2003. A prioritized research agenda for DOTS-Plus for multidrug-resistant tuberculosis (MDR-TB). Int. J. Tuberc. Lung Dis. 7(5): 410-414.PMID:12757039.
9. Hampton, T. 2005. TB drug research picks up the pace. JAMA, 293(22): 2705-2707.doi:10.1001/jama.293.22.2705. PMID: 15941790.
10. Jones, N.P., Arnason, J.T., Abou-Zaid, M., Akpagana, K., Sanchez-Vindas, P., and Smith, M.L. 2000. Antifungal activity of extracts from medicinal plants used by First Nations peoples of eastern Canada. J. Ethnopharmacol. 73(1-2): 191-198.doi:10.1016/S0378-8741(00)00306-8. PMID:11025156.
11. Kumar, M., Khan, I.A., Verma, V., Kalyan, N., and Qazi, G.N. 2005. Rapid, inexpensive MIC determination of Mycobacterium tuberculosis isolates by using microplate nitrate reductase assay. Diagn. Microbiol. Infect. Dis. 53(2): 121-124.doi:10.1016/j.diagmicrobio.2005.05.011. PMID:16168616.
12. Lacey, L. 1993. Micmac medicines. Nimbus Publishing Limited, Halifax, N.S.
13. McCutcheon, A.R., Ellis, S.M., Hancock, R.E.W., and Towers, G.H.N. 1994. Antifungal screening of medicinal plants of British Columbian native peoples. J. Ethnopharmacol. 44(3): 157-169.doi:10.1016/0378-8741(94)01183-4. PMID:7898123.
14. McCutcheon, A.R., Stokes, R.W., Thorson, L.M., Ellis, S.M., Hancock, R.E.W., and Towers, G.H.N. 1997. Anti-mycobacterial screening of British Columbian medicinal plants. Int. J. Pharmacog. 35(2): 77-83.doi:10.1076/phbi.35.2.77.13284.
15. McKee, T.C., Covington, C.D., Fuller, R.W., Bokesch, H.R., Young, S., Cardellina, J.H., II, et al. 1998. Pyranocoumarins from tropical species of the genus Calophyllum: a chemotaxonomic study of extracts in the National Cancer Institute collection. J. Nat. Prod. 61(10): 1252-1256.doi:10.1021/np980140a. PMID:9784162.
16. Mechling, W.H. 1959. The Malicite Indians, with notes on the Micmacs. Anthropologica, 8: 239-263.
17. Mitscher, L.A., and Baker, W. 1998. Tuberculosis: a search for novel therapy starting with natural products. Med. Res. Rev. 18(6): 363-374.doi:10.1002/(SICI)1098-1128(199811)18:6<363::AID-MED1>3.0. CO;2-I.
18. Moerman, D.E. 1998. Native American ethnobotany. Timber Press, Portland, Ore.
19. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65(1-2): 55-63.doi:10.1016/0022-1759(83)90303-4. PMID:6606682.
20. Nayyar, A., and Jain, R. 2005. Recent advances in new structural classes of anti-tuberculosis agents. Curr. Med. Chem. 12(16): 1873-1886.doi:10.2174/0929867054546654. PMID:16101507.
21. O'Brien, J., Wilson, I., Orton, T., and Pognan, F. 2000. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267(17): 5421-5426.doi:10.1046/j.1432-1327.2000.01606.x. PMID:10951200.
22. Rodríguez, A.D., Ramírez, C., Rodríguez, I.I., and González, E. 1999. Novel antimycobacterial benzoxazole alkaloids, from the west Indian Sea whip Pseudopterogorgia elisabethae. Org. Lett. 1(3): 527-530.doi:10.1021/ol9907116. PMID:10822593.
23. Shah, N.S., Wright, A., Bai, G.H., Barrera, L., Boulahbal, F., Martín-Casabona, N., et al. 2007. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg. Infect. Dis. 13(3): 380-387.doi:10.3201/eid1303.061400. PMID:17552090.
24. Spino, C., Dodier, M., and Sotheeswaran, S. 1998. Anti-HIV coumarins from Calophyllum seed oil. Bioorg. Med. Chem. Lett. 8(24): 3475-3478.doi:10.1016/S0960-894X(98)00628-3. PMID: 9934455.
25. Ulubelen, A., Topcu, G., and Johansson, C.B. 1997. Norditerpenoids and diterpenoids from Salvia multicaulis with antituberculous activity. J. Nat. Prod. 60(12): 1275-1280.doi:10.1021/np9700681. PMID:9428161.
26. Van Wart, A.F. 1948. The Indians of the maritime provinces, their diseases and native cures. Can. Med. Assoc. J. 59(6): 573-577.PMID:18894032.
27. Yajko, D.M., Madej, J.J., Lancaster, M.V., Sanders, C.A., Cawthon, V.L., Gee, B., et al. 1995. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J. Clin. Microbiol. 33(9): 2324-2327.PMID: 7494021.